These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 8675152)

  • 1. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.
    Kanai F; Shiratori Y; Yoshida Y; Wakimoto H; Hamada H; Kanegae Y; Saito I; Nakabayashi H; Tamaoki T; Tanaka T; Lan KH; Kato N; Shiina S; Omata M
    Hepatology; 1996 Jun; 23(6):1359-68. PubMed ID: 8675152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter.
    Ido A; Nakata K; Kato Y; Nakao K; Murata K; Fujita M; Ishii N; Tamaoki T; Shiku H; Nagataki S
    Cancer Res; 1995 Jul; 55(14):3105-9. PubMed ID: 7541712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
    Ido A; Uto H; Moriuchi A; Nagata K; Onaga Y; Onaga M; Hori T; Hirono S; Hayashi K; Tamaoki T; Tsubouchi H
    Cancer Res; 2001 Apr; 61(7):3016-21. PubMed ID: 11306481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter.
    Mawatari F; Tsuruta S; Ido A; Ueki T; Nakao K; Kato Y; Tamaoki T; Ishii N; Nakata K
    Cancer Gene Ther; 1998; 5(5):301-6. PubMed ID: 9824049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of variant-type of human alpha-fetoprotein promoter in gene therapy targeting for hepatocellular carcinoma.
    Ishikawa H; Nakata K; Mawatari F; Ueki T; Tsuruta S; Ido A; Nakao K; Kato Y; Ishii N; Eguchi K
    Gene Ther; 1999 Apr; 6(4):465-70. PubMed ID: 10476206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression.
    Kaneko S; Hallenbeck P; Kotani T; Nakabayashi H; McGarrity G; Tamaoki T; Anderson WF; Chiang YL
    Cancer Res; 1995 Nov; 55(22):5283-7. PubMed ID: 7585589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro model of suicide gene therapy for alpha-fetoprotein-producing gastric cancer.
    Nakaya H; Ishizu A; Ikeda H; Tahara M; Shindo J; Itoh R; Takahashi T; Asaka M; Ishikura H; Yoshiki T
    Anticancer Res; 2003; 23(5A):3795-800. PubMed ID: 14666679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of sensitivity to ganciclovir in human hepatocellular carcinoma cells by adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase.
    Qian C; Bilbao R; Bruña O; Prieto J
    Hepatology; 1995 Jul; 22(1):118-23. PubMed ID: 7601402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transduction efficacy, antitumoral effect, and toxicity of adenovirus-mediated herpes simplex virus thymidine kinase/ ganciclovir therapy of hepatocellular carcinoma: the woodchuck animal model.
    Bilbao R; Gérolami R; Bralet MP; Qian C; Tran PL; Tennant B; Prieto J; Bréchot C
    Cancer Gene Ther; 2000 May; 7(5):657-62. PubMed ID: 10830712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene.
    Kanai F; Lan KH; Shiratori Y; Tanaka T; Ohashi M; Okudaira T; Yoshida Y; Wakimoto H; Hamada H; Nakabayashi H; Tamaoki T; Omata M
    Cancer Res; 1997 Feb; 57(3):461-5. PubMed ID: 9012474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing human gastric carcinoma cells in vitro.
    Tanaka T; Kanai F; Okabe S; Yoshida Y; Wakimoto H; Hamada H; Shiratori Y; Lan K; Ishitobi M; Omata M
    Cancer Res; 1996 Mar; 56(6):1341-5. PubMed ID: 8640823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
    Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
    Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy for hepatocellular carcinoma: chemosensitivity conferred by adenovirus-mediated transfer of the HSV-1 thymidine kinase gene.
    Wills KN; Huang WM; Harris MP; Machemer T; Maneval DC; Gregory RJ
    Cancer Gene Ther; 1995 Sep; 2(3):191-7. PubMed ID: 8528962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatoma-specific gene therapy through retrovirus-mediated and targeted gene transfer using an adenovirus carrying the ecotropic receptor gene.
    Uto H; Ido A; Hori T; Hirono S; Hayashi K; Tamaoki T; Tsubouchi H
    Biochem Biophys Res Commun; 1999 Nov; 265(2):550-5. PubMed ID: 10558907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrovirus-mediated gene therapy for hepatocellular carcinoma with reversely oriented therapeutic gene expression regulated by alpha-fetoprotein enhancer/promoter.
    Ishikawa H; Nakata K; Mawatari F; Ueki T; Tsuruta S; Ido A; Nakao K; Kato Y; Ishii N; Eguchi K
    Biochem Biophys Res Commun; 2001 Oct; 287(4):1034-40. PubMed ID: 11573968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Construction and study of replication-defective adenovirus targeting hepatocarcinoma].
    Xu DY; Du ZY; Wang Y; Chen HH; Xu YJ; Lu YL
    Ai Zheng; 2006 Jul; 25(7):798-804. PubMed ID: 16831267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatoma cell-specific expression of a retrovirally transferred gene is achieved by alpha-fetoprotein but not insulinlike growth factor II regulatory sequences.
    Arbuthnot P; Bralet MP; Thomassin H; Danan JL; Bréchot C; Ferry N
    Hepatology; 1995 Dec; 22(6):1788-96. PubMed ID: 7489990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Target gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by E1B55k-attenuated adenovirus.
    Ohashi M; Kanai F; Tateishi K; Taniguchi H; Marignani PA; Yoshida Y; Shiratori Y; Hamada H; Omata M
    Biochem Biophys Res Commun; 2001 Mar; 282(2):529-35. PubMed ID: 11401492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AFP promoter enhancer increased specific expression of the human sodium iodide symporter (hNIS) for targeted radioiodine therapy of hepatocellular carcinoma.
    Ma XJ; Huang R; Kuang AR
    Cancer Invest; 2009 Jul; 27(6):673-81. PubMed ID: 19241193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy of experimental malignant mesothelioma using adenovirus vectors encoding the HSVtk gene.
    Esandi MC; van Someren GD; Vincent AJ; van Bekkum DW; Valerio D; Bout A; Noteboom JL
    Gene Ther; 1997 Apr; 4(4):280-7. PubMed ID: 9176512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.